Medical Properties Trust, Inc. (NYSE:MPW) was upgraded by investment analysts at ValuEngine from a “hold” rating to a “buy” rating in a research note issued on Thursday.
Several other brokerages have also recently issued reports on MPW. SunTrust Banks, Inc. restated a “buy” rating and set a $15.00 target price on shares of Medical Properties Trust in a research report on Friday, November 3rd. Zacks Investment Research upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating and set a $15.00 target price on the stock in a research report on Tuesday, October 24th. KeyCorp restated a “hold” rating on shares of Medical Properties Trust in a research report on Sunday, September 17th. Stifel Nicolaus restated a “hold” rating and set a $13.00 target price on shares of Medical Properties Trust in a research report on Friday, July 28th. Finally, Royal Bank Of Canada restated a “buy” rating and set a $16.00 target price on shares of Medical Properties Trust in a research report on Monday, July 24th. Two analysts have rated the stock with a sell rating, six have given a hold rating and seven have given a buy rating to the company’s stock. Medical Properties Trust presently has an average rating of “Hold” and an average price target of $14.18.
Medical Properties Trust (NYSE:MPW) traded down $0.05 on Thursday, hitting $13.56. 1,815,200 shares of the company’s stock traded hands, compared to its average volume of 2,052,504. Medical Properties Trust has a twelve month low of $11.57 and a twelve month high of $14.22. The company has a market cap of $4,937.96, a P/E ratio of 10.51, a PEG ratio of 2.01 and a beta of 0.95. The company has a debt-to-equity ratio of 1.26, a current ratio of 2.55 and a quick ratio of 2.06.
Medical Properties Trust (NYSE:MPW) last announced its earnings results on Thursday, November 2nd. The real estate investment trust reported $0.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.32 by $0.01. The firm had revenue of $176.60 million for the quarter, compared to analysts’ expectations of $172.57 million. Medical Properties Trust had a net margin of 39.95% and a return on equity of 7.36%. The business’s revenue was up 39.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.30 EPS. analysts forecast that Medical Properties Trust will post 1.31 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: “Medical Properties Trust, Inc. (MPW) Rating Increased to Buy at ValuEngine” was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece of content on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this piece of content can be viewed at https://ledgergazette.com/2017/11/12/medical-properties-trust-inc-mpw-rating-increased-to-buy-at-valuengine.html.
Hedge funds have recently modified their holdings of the business. Ffcm LLC bought a new position in Medical Properties Trust in the 3rd quarter worth about $116,000. IFP Advisors Inc grew its stake in Medical Properties Trust by 12.1% in the 2nd quarter. IFP Advisors Inc now owns 10,102 shares of the real estate investment trust’s stock worth $130,000 after acquiring an additional 1,093 shares in the last quarter. Blair William & Co. IL bought a new position in Medical Properties Trust in the 2nd quarter worth about $132,000. Janus Henderson Group PLC bought a new position in shares of Medical Properties Trust during the second quarter valued at approximately $136,000. Finally, Cetera Investment Advisers bought a new position in shares of Medical Properties Trust during the second quarter valued at approximately $141,000. Institutional investors and hedge funds own 84.01% of the company’s stock.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.